Safety Evaluation of Bifidobacterium breve IDCC4401 Isolated from Infant Feces for Use as a Commercial Probiotic

Previously, our research group isolated Bifidobacterium breve IDCC4401 from infant feces as a potential probiotic. For this study, we evaluated the safety of B. breve IDCC4401 using genomic and phenotypic analyses. Whole genome sequencing was performed to identify genomic characteristics and investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, In Young, Kim, Jinhee, Kim, Su-Hyeon, Ban, O-Hyun, Yang, Jungwoo, Park, Mi-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Microbiology and Biotechnology 2021
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706084/
https://www.ncbi.nlm.nih.gov/pubmed/34024895
http://dx.doi.org/10.4014/jmb.2103.03041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706084/
https://www.ncbi.nlm.nih.gov/pubmed/34024895
http://dx.doi.org/10.4014/jmb.2103.03041

Ejemplares similares